- Home
- ENB vs BMY Comparison
ENB vs BMY Comparison
Compare ENB & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENB
- BMY
- Stock Information
- Founded
- ENB 1949
- BMY 1887
- Country
- ENB Canada
- BMY United States
- Employees
- ENB N/A
- BMY N/A
- Industry
- ENB Natural Gas Distribution
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- ENB Energy
- BMY Health Care
- Exchange
- ENB Nasdaq
- BMY Nasdaq
- Market Cap
- ENB 105.4B
- BMY 94.0B
- IPO Year
- ENB N/A
- BMY N/A
- Fundamental
- Price
- ENB $49.09
- BMY $46.15
- Analyst Decision
- ENB Strong Buy
- BMY Hold
- Analyst Count
- ENB 2
- BMY 15
- Target Price
- ENB $60.50
- BMY $57.64
- AVG Volume (30 Days)
- ENB 3.2M
- BMY 9.8M
- Earning Date
- ENB 10-31-2025
- BMY 10-30-2025
- Dividend Yield
- ENB 5.43%
- BMY 5.37%
- EPS Growth
- ENB 8.96
- BMY N/A
- EPS
- ENB 2.09
- BMY 2.49
- Revenue
- ENB $47,275,380,146.00
- BMY $47,704,000,000.00
- Revenue This Year
- ENB $10.76
- BMY N/A
- Revenue Next Year
- ENB N/A
- BMY N/A
- P/E Ratio
- ENB $23.57
- BMY $18.59
- Revenue Growth
- ENB 48.17
- BMY 2.57
- 52 Week Low
- ENB $39.73
- BMY $42.96
- 52 Week High
- ENB $49.36
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- ENB 68.30
- BMY 42.96
- Support Level
- ENB $47.96
- BMY $46.00
- Resistance Level
- ENB $48.68
- BMY $46.84
- Average True Range (ATR)
- ENB 0.48
- BMY 0.93
- MACD
- ENB 0.01
- BMY -0.14
- Stochastic Oscillator
- ENB 86.38
- BMY 11.28
About ENB Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the US and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates regulated natural gas utilities in the US and Canada, including Canada's largest natural gas distribution company. The firm has a small renewable energy portfolio primarily focused on onshore and offshore wind projects.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.